Home / Healthcare / Medical Device / Breast Cancer Therapeutics Market

Breast Cancer Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, and Immunotherapy), By Cancer Type (Hormone Receptor, and HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027

Report Format: PDF | Latest Update: Feb, 2024 | Published Date: Feb, 2022 | Report ID: FBI100163 | Status : Published


















































  ATTRIBUTE



  DETAILS



Study Period



  2016-2027



Base Year



  2019



Forecast Period



  2020-2027



Historical Period



  2016-2018



Unit



  Value (USD billion)



Segmentation



  Therapy, Cancer Type, Distribution Channel, and Geography



By Therapy


 




  • Targeted Therapy


    • Abemaciclib

    • Ado-Trastuzumab Emtansine

    • Everolimus

    • Trastuzumab

    • Ribociclib

    • Palbociclib

    • Pertuzumab

    • Olaparib

    • Others




  • Hormonal Therapy

    • Selective Estrogen Receptor Modulators (SERMs)

    • Aromatase Inhibitors

    • Estrogen Receptor Downregulators (ERDs)



  • Chemotherapy

  • Immunotherapy



By Cancer Type


 




  • Hormone Receptor

  • HER2+



By Distribution Channel


 




  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

  • Others



By Geography


 




  • North America

    • By Therapy

    • By Cancer Type

    • By Distribution Channel

    • By Country

      • U.S.

      • Canada





  • Europe

    • By Therapy

    • By Cancer Type

    • By Distribution Channel

    • By Country/ Sub-Region

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Scandinavia

      • Rest of Europe





  • Asia Pacific

    • By Therapy

    • By Cancer Type

    • By Distribution Channel

    • By Country/ Sub-Region

      • Japan

      • China

      • India

      • Australia

      • South East Asia

      • Rest of Asia Pacific





  • Latin America

    • By Therapy

    • By Cancer Type

    • By Distribution Channel

    • By Country/ Sub-Region

      • Brazil

      • Mexico

      • Rest of South America





  • Middle East & Africa

    • By Therapy

    • By Cancer Type

    • By Distribution Channel

    • By Country/ Sub-Region

      • South Africa

      • GCC Countries

      • Rest of Middle East & Africa






  • Global
  • 2019
  • 2016-2018
  • 175
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Buy Now

Healthcare Clients